Last updated: August 28, 2025
Introduction
Israel Patent IL167835 pertains to a broadly applicable pharmaceutical innovation registered within Israel’s national patent system. As an integral element of strategic drug development and intellectual property (IP) management, understanding its scope and claims offers insight into its market exclusivity, potential licensing opportunities, and competitive positioning. This analysis explores the patent’s technical scope, claim structure, and its positioning within the global patent landscape.
Patent Overview and Technical Background
Patent IL167835 was granted in Israel to foster proprietary rights over a specific drug formulation or method of treatment. While the exact title and patent specification details are not directly provided here, standard practice suggests that such patents often cover:
- Novel compounds or drug derivatives.
- Unique formulations or delivery systems.
- Methods of manufacturing.
- Therapeutic methods utilizing the compound.
Assuming the patent’s central subject involves a novel chemical entity or therapeutic regimen, the scope is likely designed to prevent unauthorized manufacturing, use, or sale within Israel, aligning with international practices for pharmaceutical patents.
Scope of the Patent
The scope of IL167835 is determined primarily by its claims, which define the legal boundaries of patent protection. The patent’s claims include independent and dependent claims structured to cover the core inventive concept and its specific embodiments.
1. Core Claim Scope:
- Main Claim: Usually claims a novel compound, formulation, or method of treatment. For example, a claim might specify a chemical compound with a particular structure, potentially characterized by a set of substituents or functional groups.
- Method Claims: May protect the specific method of synthesizing the compound or administering it therapeutically.
- Formulation Claims: Cover the drug in particular compositions, such as sustained-release or targeted delivery systems.
2. Claim Limitations and Scope:
- Chemical specificity: Claims tend to specify precise chemical structures with scope limited to particular derivatives.
- Method limitations: If therapeutic methods are claimed, they usually specify dosage, route of administration, or treatment regimen.
- Distinguishing features: Claims are crafted to differentiate from prior art, emphasizing novel structural elements or unexpectedly improved efficacy.
Claims Analysis
An in-depth claim analysis involves examining the independent claims first, then the dependent claims that specify particular embodiments or variations.
Example (Hypothetical Scenario):
- Independent Claim: Claim to a compound of formula (I), where X, Y, Z are defined variables, with a pharmacologically active property.
- Dependent Claims: Further specify the substituents, stereochemistry, crystalline forms, or specific uses in treatment of particular diseases, e.g., cancer, neurological disorders, etc.
Key considerations:
- Breadth: The patent’s claim breadth influences its enforceability and resilience to challenges. Broad chemical structure claims offer extensive protection but risk invalidity if found to encompass prior art.
- Specificity: Narrow claims targeting specific compounds or methods reduce invalidity risk but limit enforcement scope.
- Doctrine of Equivalence: Variations outside the literal claim language may still infringe under this doctrine if they perform substantially the same function.
Patent Landscape in Israel and Globally
1. Israel Patent Environment:
Israel follows the Patents Law 1967, harmonized with international standards such as the Patent Cooperation Treaty (PCT). The patent landscape for pharmaceuticals in Israel is marked by:
- A focus on innovative medicinal compounds and formulations.
- Active patent examination, emphasizing novelty, inventive step, and industrial applicability.
- A robust litigation environment for patent enforcement.
2. Related Patent Families and Priority:
IL167835 may belong to a patent family filed internationally via the PCT or direct national applications in jurisdictions such as the US, Europe, China, and others. Cross-jurisdictional patent protection enhances market coverage and provides leverage in licensing or partnerships.
3. Similar and Prior Art Analysis:
Key prior art includes:
- Existing drugs with similar chemical frameworks.
- Prior publications describing analogous compounds or treatment methods.
- Earlier patents with overlapping claims.
Assessing the novelty and inventive step involves mapping IL167835 against prior art, emphasizing distinctions over existing treatments or compounds.
4. Competitive Patent Landscape:
Major pharmaceutical companies and biotech firms often file patents on similar therapeutic targets—especially for disease-specific drugs. The patent’s scope must be sufficiently unique to avoid patent thickets and to withstand invalidity or non-infringement claims.
Legal and Commercial Implications
1. Market Exclusivity:
- The patent grants IL167835 a limited-term monopoly (typically 20 years from filing) to commercialize the covered drug.
- Effective patent claims and broad scope allow the patent holder to deter competitors and establish market dominance.
2. Licensing and Collaborations:
- The patent’s scope influences licensing negotiations—broad claims are more attractive to licensees.
- Strategic licensing can expand the drug’s geographical reach beyond Israel.
3. Patent Challenges and Defenses:
- Competitors may challenge validity citing prior art or obviousness.
- Patent holder can defend by emphasizing novelty, inventive step, and specific claim limitations.
Conclusion
Israel Patent IL167835 exemplifies a strategic patent covering potentially critical aspects of a therapeutic compound or method. Its scope, shaped by carefully drafted claims, seeks to balance broad protection with defensibility against prior art. The patent’s position within Israel’s active pharmaceutical landscape, along with its international counterparts, emphasizes its role in safeguarding innovative drug development and fostering commercial advantage.
Key Takeaways
- The patent’s claims define the precise scope, balancing broadness with defensibility.
- Maintaining awareness of global patent counterparts strengthens market positioning.
- Strategic claim drafting enhances enforceability and reduces invalidity risks.
- The patent landscape in Israel favors robust protection aligned with international standards.
- Continuous monitoring of prior art and potential challenges is vital for patent maintenance and enforcement.
FAQs
Q1: How does IL167835's claim scope influence its market exclusivity?
A1: Broad claims can extend protection over a wider range of derivatives or methods, thereby strengthening market exclusivity. Narrow claims limit protection but can be easier to defend against invalidity challenges.
Q2: Can IL167835 be enforced outside Israel?
A2: Not directly. Enforcing the patent internationally requires filing corresponding applications in other jurisdictions, either via PCT or direct filings, to establish multi-national protection.
Q3: What are common challenges faced by pharmaceutical patents like IL167835?
A3: Challenges include prior art invalidity claims, obviousness arguments, and claims construction disputes, which can weaken enforceability.
Q4: How does the patent landscape impact drug development strategies?
A4: A robust patent landscape can incentivize innovation, guide licensing negotiations, and influence the timing of clinical and regulatory milestones.
Q5: What should patent holders do to maintain patent strength over time?
A5: Regularly monitor patent validity, defend against infringement, and consider patent term extensions or supplementary protection certificates where permitted.
References
- Israeli Patent Law, 1967.
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT).
- OECD/IP data on pharmaceutical patents.
- Patent data and prior art mappings in the pharmaceutical sector.
- National patent office resources for Israel.
Note: Due to the absence of explicit claim language and detailed specifications, this analysis is based on standard practices and logical inference within pharmaceutical patent law. For precise legal advice or specific claim language interpretation, consulting the official patent documents or a patent attorney is recommended.
